Earnings History Data for Capricor Therapeutics, Inc. (CAPR) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Capricor Therapeutics, Inc.

Capricor Therapeutics, Inc. is a biotechnology company. It is focused on the development of novel therapeutics to prevent and treat heart disease. The Company has two drug candidates in development: Cenderitide and CU-NP. Capricor Therapeutics, Inc., formerly known as Nile Therapeutics, Inc., is based in San Mateo, California.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
10-11-2022	AH	4:05 PM ET (Nov 10)	CAPR	Capricor Therapeutics, Inc.	119.05	-0.26	-0.28	-0.17	Capricor Therapeutics GAAP EPS of -$0.26 beats by $0.05, revenue of $1.59M beats by $1.45M [11/10/2022 4:03 PM]	4.55	-0.35 (-7.14%)	4.90	0.0 (0.00%)	2.56 - 6.58	200,402	140,000	175
Capricor Therapeutics GAAP EPS of -$0.26 beats by $0.05, revenue of $1.59M beats by $1.45M [11/10/2022 4:03 PM] Capricor Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update [Nov-10-22 04:01PM]
10-08-2022	AH	4:00 PM ET (Aug 10)	CAPR	Capricor Therapeutics, Inc.	108.00	-0.29	-0.25	-0.21	Capricor Therapeutics GAAP EPS of -$0.29 misses by $0.03 [8/10/2022 4:14 PM]	5.30	0.78 (17.26%)	4.70	0.18 (3.98%)	2.56 - 5.85	546,716	100,000	12,816
Capricor Therapeutics GAAP EPS of -$0.29 misses by $0.03 [8/10/2022 4:14 PM] Capricor stock rises 16% after update on muscular dystrophy treatment, Q2 results [8/11/2022 12:02 PM] Capricor Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update [Aug-10-22 04:05PM]
10-05-2022	AH	4:00 PM ET (May 10)	CAPR	Capricor Therapeutics, Inc.	84.89	-0.32	0.00	-0.23	Capricor Therapeutics GAAP EPS of -$0.32 [5/10/2022 4:06 PM]	2.91	-0.32 (-9.95%)	3.18	0.06 (1.92%)	2.56 - 6.22	107,902	90,000	120
Capricor Therapeutics GAAP EPS of -$0.32 [5/10/2022 4:06 PM] Capricor Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update [May-10-22 04:01PM]
10-03-2022	AH	4:05 PM ET (Mar 10)	CAPR	Capricor Therapeutics, Inc.	106.98	-0.26	-0.19	-0.21		4.22	0.10 (2.43%)	4.24	0.12 (2.91%)	2.56 - 6.22	166,951	180,000	4,058
Capricor Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update [Mar-10-22 04:01PM] The Lancet Publishes Positive Results from Capricor Therapeutics Phase 2 Study Evaluating CAP-1002 in Late-Stage Duchenne Muscular Dystrophy [Mar-11-22 08:00AM]
09-11-2021	AH	4:00 PM ET (Nov 9)	CAPR	Capricor Therapeutics, Inc.	87.71	-0.17	-0.22	-0.20	Capricor Therapeutics EPS beats by $0.06 [11/9/2021 4:09 PM]	3.50	-0.12 (-3.31%)	3.62	0.0 (0.00%)	3.13 - 8.40	257,395	160,000	4,734
Capricor Therapeutics EPS beats by $0.06 [11/9/2021 4:09 PM] Capricor Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update [Nov-09-21 04:05PM] Capricor Therapeutics (CAPR) Reports Q3 Loss, Lags Revenue Estimates [Nov-09-21 06:45PM]
12-08-2021	AH	4:05 PM ET (Aug 12)	CAPR	Capricor Therapeutics, Inc.	102.04	-0.21	-0.23	-0.23	Capricor Therapeutics EPS beats by $0.02, misses on revenue [8/12/2021 4:13 PM]	4.03	-0.44 (-9.93%)	4.08	-0.40 (-8.93%)	3.13 - 8.40	411,531	110,000	32,880
Capricor Therapeutics EPS beats by $0.02, misses on revenue [8/12/2021 4:13 PM] Capricor Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update [Aug-12-21 04:01PM]
13-05-2021	AH	4:00 PM ET (May 13)	CAPR	Capricor Therapeutics, Inc.	80.48	-0.23	0.00	-0.30	Capricor Therapeutics reports Q1 results [5/13/2021 4:21 PM]	3.64	0.48 (15.19%)	3.35	0.19 (6.01%)	3.13 - 12.32	620,944	520,000	2,699
Capricor Therapeutics reports Q1 results [5/13/2021 4:21 PM] Capricor to Present at the American Society of Gene and Cell Therapys 24th Annual Meeting [May-12-21 09:00AM] Capricor Therapeutics, Inc. to Host Earnings Call [May-13-21 02:30PM] Capricor Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update [May-13-21 04:05PM]
11-03-2021	AH	4:00 PM ET (Mar 11)	CAPR	Capricor Therapeutics, Inc.	105.30	-0.21	0.00	-0.34	Capricor Therapeutics EPS misses by $0.01 [3/11/2021 4:04 PM]	5.18	-0.36 (-6.59%)	4.88	-0.66 (-11.91%)	0.88 - 12.32	504,669	423,807	22,425
Capricor Therapeutics EPS misses by $0.01 [3/11/2021 4:04 PM] Capricor Therapeutics, Inc. to Host Earnings Call [Mar-11-21 02:30PM] Capricor Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update [Mar-11-21 04:01PM]
12-11-2020	AH	4:00 PM ET (Nov 12)	CAPR	Capricor Therapeutics, Inc.	83.43	-0.20	0.00	-0.43	Capricor Therapeutics reports Q3 results [11/12/2020 4:07 PM]	4.34	-0.30 (-6.56%)	4.22	-0.43 (-9.25%)	0.88 - 12.32	400,311	711,590	6,045

06-08-2020	AH	4:00 PM ET (Aug 6)	CAPR	Capricor Therapeutics, Inc.	109.55	-0.23	-0.37	-0.59	Capricor Therapeutics EPS beats by $0.11 [8/6/2020 4:05 PM]	6.48	-1.42 (-17.97%)	6.49	-1.41 (-17.85%)	0.88 - 12.32	3,732,419	8,324,786	215,305